Variation spectrum and reevaluation of selected VUS of ATP7B in a Chinese Wilson disease cohort

Abstract

Aim: The clinical diagnosis of Wilson disease (WD) remains challenging due to ethnic and phenotypic heterogeneity, as well as the high prevalence of variants of unknown significance (VUS). This study aimed to update the genetic variation spectrum in the Chinese population and reevaluate a subset of VUS to improve the accuracy of genetic diagnosis.

Methods: Patients suspected of having WD and known non-WD controls were selected and underwent ATP7B-targeted sequencing. The variant spectrum was analyzed. Recurrent VUS, particularly those associated with very low ceruloplasmin levels, were further evaluated based on mutational characteristics, including pathogenic variant linkage disequilibrium and zygosity.

Results: We analyzed a total of 679 WD suspects and 251 controls. Of these, 292 patients (282 cases) carried disease-causing variants or VUS. Demographic characteristics were comparable between groups. The most recurrent pathogenic variants - p.Arg778Leu, p.Pro992Leu, and p.Ala874Val - differed significantly from those observed in the Caucasian population. Among the 79 detected VUS, 26 were novel. The most frequent VUS included p.Leu770=, p.Val1297Ile, p.Val1106Ile, p.Ile929Val, p.Ala1003=, p.Ala476Thr, and p.Asp196Glu. Following reevaluation of 9 VUS, we classified p.Val1106Ile, the splice-site variant c.1543+40G>A, p.Ala1018Val, p.Leu1088Ser, p.Gly1335Arg, and the synonymous variants p.Ile1338= and p.Ala1003= as pathogenic candidates. Notably, p.Val1106Ile frequently co-occurred with pathogenic mutations, while p.Leu770= was reclassified as a tag-only variant.

Conclusion: Our study reveals a distinct mutation spectrum in the Chinese population, providing evidence supporting the classification of VUS. The unique mutational patterns observed at specific loci suggest their potential structural significance within the ATP7B protein.

Keywords

Wilson disease / ATP7B / liver / ceruloplasmin / VUS / pathogenic

References

[1] Roberts EA,Schilsky ML. Current and emerging issues in Wilson’s disease N Engl J Med. 2023 389 922 38

[2] Calinas F,Cardoso H,Carvalhana S.et al. Practical and multidisciplinary review on Wilson disease: the Portuguese perspective GE Port J Gastroenterol. 2024 1 17 PMC11936444

[3] Wang M,Wang F,Tao Z,Yang W. Analysis of factors affecting early hepatic steatosis in pediatric patients with Wilson’s disease in China: a retrospective study Medicine (Baltimore). 2025 104 e45501

[4] Najimi Z,Elsaboni L,Mtegha M.et al. Analysis of tissue copper levels as a reliable diagnostic tool in paediatric liver disease Eur J Pediatr. 2025 185 23

[5] Ferenci P,Caca K,Loudianos G.et al. Diagnosis and phenotypic classification of Wilson disease¹ Liver Int. 2003 23 139 42

[6] Stenson PD,Mort M,Ball EV.et al. The Human Gene Mutation Database (HGMD®): optimizing its use in a clinical diagnostic or research setting Hum Genet. 2020 139 1197 207 PMC7497289

[7] Rehm HL,Berg JS,Brooks LD.et al. ClinGen - the clinical genome resource N Engl J Med. 2015 372 2235 42

[8] Zhang SJ,Yang WM,Yang YL,Wang JX,He W. Analysis of clinical phenotype and ATP7B variants characteristics of 337 patients with hepatolenticular degeneration in Anhui province. Zhonghua Yi Xue Za Zhi. 2025;105:1172-6.(in Chinese)

[9] Mishra AK,Sen Sarma M,Moirangthem A,Sait H. Nuances in ATP7B Genetic Testing and Interpretation in India J Clin Exp Hepatol. 2026 16 103205 PMC12621440

[10] Xu W,Wang R,Dong Y,Wu Z. Pathogenicity of intronic and synonymous variants of ATP7B in Wilson Disease J Mol Diagn. 2023 25 57 67

[11] Han M,Yang Z. A rare presentation of Wilson disease with normal levels of serum ceruloplasmin and copper and MODY: A case report Medicine (Baltimore). 2025 104 e43080

[12] Socha P,Jańczyk W,Zanetto A.et al. EASL-ERN clinical practice guidelines on Wilson’s disease J Hepatol. 2025 82 690 728

[13] Palumbo CS,Schilsky ML. Clinical practice guidelines in Wilson disease Ann. Transl. Med. 2019 7 Suppl S65 PMC6531645

[14] Cao H,Chen Y,Fan J. Wilson’s disease: from clinical practice to guidelines Zhonghua Gan Zang Bing Za Zhi. 2014 22 570 2

[15] Tang S,Hou W,Zheng SJ. Recommendations from the European Association for the study of the liver and the European reference network for rare liver diseases clinical practice guidelines for hepatolenticular degeneration Zhonghua Gan Zang Bing Za Zhi. 2025 33 988 992 (in Chinese)

[16] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Wilson’s disease J Hepatol. 2012 56 671 85

[17] Li X,Lu Y,Ling Y.et al. Clinical and molecular characterization of Wilson’s disease in China: identification of 14 novel mutations BMC Med Genet. 2011 12 6 PMC3025937

[18] Richards S,Aziz N,Bale S.et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med. 2015 17 405 24 PMC4544753

[19] Gargano MA,Matentzoglu N,Coleman B.et al. The Human Phenotype Ontology in 2024: phenotypes around the world Nucleic Acids Res. 2024 52 D1333 46 PMC10767975

[20] Landrum MJ,Lee JM,Benson M.et al. ClinVar: improving access to variant interpretations and supporting evidence Nucleic Acids Res. 2018 46 D1062 7 PMC5753237

[21] Francomano CA. Victor Almon McKusick: in the footsteps of Mendel and Osler American J of Med Genetics Pt A. 2021 185 3193 201

[22] Amberger JS,Bocchini CA,Schiettecatte F,Scott AF,Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders Nucleic Acids Res. 2015 43 D789 98 PMC4383985

[23] Auton A,Abecasis GR,Altshuler DM.et al. ; Writing group. A global reference for human genetic variation Nature. 2015 526 68 74 PMC4750478

[24] Karczewski KJ,Francioli LC,Tiao G.et al. ; Genome Aggregation Database Consortium. The mutational constraint spectrum quantified from variation in 141,456 humans Nature. 2020 581 434 43

[25] Phan L,Zhang H,Wang Q.et al. The evolution of dbSNP: 25 years of impact in genomic research Nucleic Acids Res. 2025 53 D925 31 PMC11701571

[26] Niehaus A,Azzariti DR,Harrison SM.et al. A survey assessing adoption of the ACMG-AMP guidelines for interpreting sequence variants and identification of areas for continued improvement Genet Med. 2019 21 1699 701 PMC7233466

[27] Ryan A,Nevitt SJ,Tuohy O,Cook P. ; Cochrane Cystic Fibrosis and Genetic Disorders Group. Biomarkers for diagnosis of Wilson’s disease Cochrane Database Syst Rev. 2019 2019 PMC6953362

[28] Hart RK,Fokkema IFAC,Distefano M.et al. HGVS Nomenclature 2024: improvements to community engagement, usability, and computability Genome Med. 2024 16 149 PMC11660784

[29] Ghosh U,Sen Sarma M,Samanta A. Challenges and dilemmas in pediatric hepatic Wilson’s disease World J Hepatol. 2023 15 1109 26 PMC10642431

[30] Stättermayer AF,Entenmann A,Gschwantler M,Zoller H,Hofer H,Ferenci P. The dilemma to diagnose Wilson disease by genetic testing alone Eur J Clin Investig. 2019 49 e13147 PMC6772051

[31] Møller LB,Horn N,Jeppesen TD.et al. Clinical presentation and mutations in Danish patients with Wilson disease Eur J Hum Genet. 2011 19 935 41 PMC3179371

[32] Couchonnal E,Bouchard S,Sandahl TD.et al. ATP7B variant spectrum in a French pediatric Wilson disease cohort Eur J Med Genet. 2021 64 104305

[33] Garbuz M,Ovchinnikova E,Ovchinnikova A.et al. Spectrum of pathogenic variants of the ATP7B gene and genotype-phenotype correlation in eastern Eurasian patient cohorts with Wilson’s disease Biomedicines. 2024 12 2833

[34] Kumar M,Sharma S,Pandey S.et al. The genomic landscape of Wilson disease in a pan India disease cohort and population-scale data Movement Disord Clin Pract. 2024 12 185 95

[35] Deignan JL,Chung WK,Kearney HM,Monaghan KG,Rehder CW,Chao EC. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG) Genet Med. 2019 21 1267 70 PMC6559819

[36] Zhang Q,Xie X,Li H,Li Y,Huang H. Silent but significant: Functional elucidation of a synonymous ATP7B mutation in Wilson’s disease pedigrees Front. Genet. 2025 16 1604683 PMC12186502

[37] Panzer M,Viveiros A,Schaefer B.et al. Synonymous mutation in adenosine triphosphatase copper‐transporting beta causes enhanced exon skipping in Wilson disease Hepatol Commun. 2022 6 1611 9 PMC9234614

[38] Zhou X,Zhou W,Wang C.et al. A comprehensive analysis and splicing characterization of naturally occurring synonymous variants in the ATP7B gene Front. Genet. 2021 11 592611 PMC7947925

[39] Girardini KN,Olthof AM,Kanadia RN. Introns: the “dark matter” of the eukaryotic genome Front. Genet. 2023 14 1150212 PMC10228655

[40] Collins CJ,Yi F,Dayuha R.et al. Direct measurement of ATP7B peptides is highly effective in the diagnosis of Wilson disease Gastroenterology. 2021 160 2367 2382.e1 PMC8243898

[41] Mariño Z,Schilsky ML. Wilson disease: novel diagnostic and therapeutic approaches Semin Liver Dis. 2024 45 221 35 PMC12962356